Skip to main content
. 2021 May 13;29:47–53. doi: 10.1016/j.ctro.2021.05.004

Table 4.

Acute Toxicity Details.

HDR-BT Upfront
(n = 58)
IMRT Upfront
(n = 57)
G1 G2 G3 G4/5 G1 G2 G3 G4/5
GU
Frequency 32 (65.5%) 9 (10.3%) 0 0 32 (56.1%) 12 (21.1%) 0 0
Urgency 27 (46.5%) 5 (8.6%) 0 0 36 (63.2%) 3 (5.3%) 0 0
Dysuria 26 (44.8%) 0 0 0 28 (49.1%) 0 0 0
Obstruction 22 (37.9%) 18 (31.0%) 1 (1.7%) 0 24 (42.1%) 19 (33.3%) 0 0
Incontinence 3 (5.2%) 1 (1.7%) 0 0 10 (17.5%) 2 (3.5%) 0 0
Hematuria 24 (41.4%) 1 (1.7%) 1 (1.7%) 0 31 (54.4%) 1 (1.8%) 0 0
Temporary
Catheter Placement Required
0 4 (6.9%) 1 (1.7%) 0 0 3 (5.3%) 0 0



GI
Diarrhea 28 (50.9%) 0 1 (1.7%) 0 17 (29.8%) 2 (3.5%) 0 0
Rectal Pain 8 (13.8%) 0 0 0 25 (43.9%) 0 0 0
Proctitis 7 (12.1%) 5 (8.6%) 0 0 14 (24.6%) 4 (7.0%) 0 0